PFBT
KRYS icon

Parkside Financial Bank & Trust’s Krystal Biotech KRYS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2K Buy
49
+15
+44% +$4.48K ﹤0.01% 1415
2026
Q1 		$8.78K Buy
34
+1
+3% +$266 ﹤0.01% 1631
2025
Q4 		$8.14K Buy
33
+8
+32% +$1.68K ﹤0.01% 1654
2025
Q3 		$4.42K Buy
25
+10
+67% +$1.5K ﹤0.01% 1775
2025
Q2 		$2.06K Sell
15
-6
-29% -$881 ﹤0.01% 1996
2025
Q1 		$3.79K Buy
21
+18
+600% +$3.03K ﹤0.01% 1717
2024
Q4 		$470 Buy
3
+1
+50% +$177 ﹤0.01% 1884
2024
Q3 		$365 Hold
2
– – ﹤0.01% 1888
2024
Q2 		$368 Buy
+2
New +$336 ﹤0.01% 1835

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Parkside Financial Bank & Trust's KRYS Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Krystal Biotech (KRYS) stake by 44% in Q2 2026, buying an estimated $4.48K and bringing the position to 49 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

Parkside Financial Bank & Trust first reported a position in KRYS in Q2 2024 and has held it in 9 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Parkside Financial Bank & Trust held 49 shares of Krystal Biotech worth $18.2K as of Q2 2026.
  • Parkside Financial Bank & Trust bought 15 Krystal Biotech shares in Q2 2026, an estimated $4.48K.
  • Krystal Biotech made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1415 holding.
  • Parkside Financial Bank & Trust first reported a position in Krystal Biotech in Q2 2024 and has held it in 9 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.